Search details
1.
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.
Diabetes Obes Metab
; 26(6): 2188-2198, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38425186
2.
Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trial.
Diabetes Obes Metab
; 25(7): 1865-1873, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36872067
3.
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study).
Diabetes Obes Metab
; 22(2): 173-181, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31502749
4.
Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat hearts.
Pflugers Arch
; 470(2): 263-275, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29032504
5.
Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice.
Exp Mol Med
; 55(4): 767-778, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37009790
6.
Dyslipidemia Fact Sheet in South Korea, 2022.
Diabetes Metab J
; 47(5): 632-642, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37528532
7.
Dyslipidemia Fact Sheet in South Korea, 2022.
J Lipid Atheroscler
; 12(3): 237-251, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37800108
8.
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension.
Diabetes Metab J
; 47(6): 808-817, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37750183
9.
Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study.
Diabetes Care
; 45(10): 2224-2230, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-35984640
10.
Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study).
Diabetes Metab J
; 46(1): 81-92, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34130378
11.
Analysis of clinical phenotypes of neuropathic symptoms in patients with type 2 diabetes: A multicenter study.
J Diabetes Investig
; 13(11): 1852-1860, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35779248
12.
The FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC) trial.
Hypertens Res
; 45(12): 2008-2017, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36123398
13.
A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus.
Diabetes Metab J
; 46(6): 855-865, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35255547
14.
Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha overexpression prevents endothelial apoptosis by increasing ATP/ADP translocase activity.
Arterioscler Thromb Vasc Biol
; 30(2): 290-7, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-19965780
15.
Alpha-lipoic acid activates dimethylarginine dimethylaminohydrolase in cultured endothelial cells.
Biochem Biophys Res Commun
; 398(4): 653-8, 2010 Aug 06.
Article
in English
| MEDLINE | ID: mdl-20603107
16.
Type 2 diabetes in urban and rural districts in Korea: factors associated with prevalence difference.
J Korean Med Sci
; 25(12): 1777-83, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-21165294
17.
Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis.
Nat Neurosci
; 9(7): 901-6, 2006 Jul.
Article
in English
| MEDLINE | ID: mdl-16783365
18.
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study.
Diabetes Ther
; 11(4): 859-871, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32065359
19.
γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial.
Diabetes Metab J
; 44(4): 542-554, 2020 08.
Article
in English
| MEDLINE | ID: mdl-31701699
20.
BH4 activates CaMKK2 and rescues the cardiomyopathic phenotype in rodent models of diabetes.
Life Sci Alliance
; 3(9)2020 09.
Article
in English
| MEDLINE | ID: mdl-32699151